Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.
Straatmijer T, Biemans VBC, Moes DJAR, Hoentjen F, Ter Heine R, Maljaars PWJ, Theeuwen R, Pierik M, Duijvestein M, van der Meulen-de Jong AE; Dutch Initiative on Crohn’s and Colitis (ICC). Straatmijer T, et al. Among authors: moes djar. Dig Dis Sci. 2023 Jun;68(6):2647-2657. doi: 10.1007/s10620-023-07822-7. Epub 2023 Mar 15. Dig Dis Sci. 2023. PMID: 36920666 Free PMC article.
Physiologically-based pharmacokinetic modeling of quinidine to establish a CYP3A4, P-gp, and CYP2D6 drug-drug-gene interaction network.
Feick D, Rüdesheim S, Marok FZ, Selzer D, Loer HLH, Teutonico D, Frechen S, van der Lee M, Moes DJAR, Swen JJ, Schwab M, Lehr T. Feick D, et al. Among authors: moes djar. CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1143-1156. doi: 10.1002/psp4.12981. Epub 2023 May 23. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37165978 Free PMC article.
Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more.
Boone NW, Moes DJAR, Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Gronenschild M, van Haren E, Buijs J, de Vries A, Peeters R, Landewé RBM, Wong DR. Boone NW, et al. Among authors: moes djar. Br J Clin Pharmacol. 2023 Feb 15. doi: 10.1111/bcp.15690. Online ahead of print. Br J Clin Pharmacol. 2023. PMID: 36791777 Free article.
Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation.
Zwart TC, Bezstarosti S, Achini FR, Reinders MEJ, Schilham MW, Heidt S, Guchelaar HJ, de Fijter JW, Moes DJAR. Zwart TC, et al. Among authors: moes djar. Br J Clin Pharmacol. 2023 Apr;89(4):1471-1485. doi: 10.1111/bcp.15608. Epub 2022 Dec 9. Br J Clin Pharmacol. 2023. PMID: 36408784 Free article.
A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages.
Swets MC, Moss RJ, Kor F, Hilarius D, Moes DJAR, Berkhout WE, van den Toorn LM, van den Oever NCG, de Valk R, Rosendaal FR, Hunfeld N, Groeneveld GH, de Boer MGJ. Swets MC, et al. Among authors: moes djar. Int J Infect Dis. 2023 Apr;129:57-62. doi: 10.1016/j.ijid.2023.01.041. Epub 2023 Feb 2. Int J Infect Dis. 2023. PMID: 36738957 Free PMC article.
95 results